FDA Inspection 1199978 — Jell Pharmaceuticals Pvt. Ltd.

Jell Pharmaceuticals Pvt. Ltd. — FEI 3005205440

The FDA completed an inspection of Jell Pharmaceuticals Pvt. Ltd. on March 17, 2023 in Silvassa. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 17, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Silvassa (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed